Guardion’s Proprietary Medical Device, the MapcatSF®, Receives Patent from the European Union
Guardion Health Sciences, Inc. (GHSI)
Company Research
Source: GlobeNewswire
San Diego, CA, June 20, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), an ocular health sciences and technologies company that develops, formulates and distributes condition-specific medical foods and testing technologies supported by evidence-based protocols, announced that it has received a patent from the European Union (European Patent No. 2,811,892 titled “Apparatus for Use in the Measurement of Macular Pigment Optical Density and/or Lens Optical Density of an Eye”) for its proprietary medical device, the MapcatSF®. The MapcatSF® measures the macular pigment density in the human eye, thus facilitating treatment for several ocular conditions and diseases that affect a large number of patients. Michael Favish, Guardion’s Chief Executive Officer, commenting on the granting of this patent by the European Union, stated, “The granting of this patent is another building block in our efforts to build an international portfol
Show less
Read more
Impact Snapshot
Event Time:
GHSI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GHSI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GHSI alerts
High impacting Guardion Health Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GHSI
News
- Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching [Yahoo! Finance]Yahoo! Finance
- Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023 [Yahoo! Finance]Yahoo! Finance
- Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023GlobeNewswire
- Guardion Health Sciences, Inc. (NASDAQ: GHSI) had its "hold" rating re-affirmed by analysts at Maxim Group.MarketBeat
- Thinking about buying stock in Guardion Health Sciences, Minim, Revelation Biosciences, Nyxoah, or Pixelworks?PR Newswire
GHSI
Sec Filings
- 4/9/24 - Form 8-K
- 4/8/24 - Form DEFM14A
- 4/3/24 - Form 3
- GHSI's page on the SEC website